TEYRO LABS
GenericsTEYRO LABS is a generic drug manufacturer focused on Oncology, Gastroenterology.
TEYRO LABS's Key Drugs
TEYRO LABS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
TEYRO LABS's Recent FDA Approvals
New NDA/BLA approvals for TEYRO LABS over the last two years — novel drugs only, excluding generics and label supplements.
TEYRO LABS's Therapeutic Areas
TEYRO LABS's approved drugs and pipeline span 2 therapeutic areas, led by Oncology and Gastroenterology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
TEYRO LABS's Top Competitors
TEYRO LABS's closest competitors by therapeutic-area and drug-target overlap include Johnson & Johnson, Bristol-Myers Squibb, and Takeda. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
TEYRO LABS Pipeline Snapshot
Active clinical trials for TEYRO LABS across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Oncology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2007-01-18
- Latest
- 2024-09-24
- Applications
- 4